Small-molecule targeting of kinesin-13 KIF2C enhances double-strand break DNA repair and slows down aging

Abstract DNA damage is a central driver of the aging process. We previously found that KIF2C, known to play a role in DNA repair, is repressed in aged cells. Here, we investigated if increased KIF2C activity counteracts DNA damage and its effects on aging phenotypes. We show that a small-molecule agonist of KIF2C enhances DNA repair in two distinct genetic disorders exhibiting DNA damage and accelerated aging, the Hutchinson-Gilford progeria (HGPS) and Down (DS) syndromes. Mechanistically, the KIF2C agonist improves the repair of DNA double-strand breaks by inducing nuclear envelope invaginations poked by cytoplasmic microtubules, which translated into amended epigenetic and transcriptional signatures of HGPS and DS. Moreover, subcutaneous administration of the KIF2C agonist in progeria mice mitigated aging phenotypes, extending their healthspan. Our study discloses a unique geroprotective pharmacological approach targeting DNA damage.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-11-01
DOI
https://doi.org/10.1038/s41467-026-79165-6
Citations
2
Primary Topic
Nuclear Structure and Function
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Small-molecule targeting of kinesin-13 KIF2C enhances double-strand break DNA repair and slows down aging

Paula Sampaio, Joana Magalhães, Elsa D. Silva, Carlos Sousa-Soares et al.
2 citations
Nature Communications
Nuclear Structure and Function
article

Small-molecule targeting of kinesin-13 KIF2C enhances double-strand break DNA repair and slows down aging

Paula Sampaio, Joana Magalhães, Elsa D. Silva, Carlos Sousa-Soares, Francisco Vasques‐Nóvoa, Rui Ribeiro, Elsa Logarinho, Vera A. Gorbunova, Mafalda Sousa, Mafalda Galhardo, Monika Barroso‐Vilares, Andrei Seluanov, Diana Santos Nascimento, Joana Martins‐Macedo, Marcos Antonio Barbosa Da Silva, M. Inês Ala
article en
2 citations

Abstract

Abstract DNA damage is a central driver of the aging process. We previously found that KIF2C, known to play a role in DNA repair, is repressed in aged cells. Here, we investigated if increased KIF2C activity counteracts DNA damage and its effects on aging phenotypes. We show that a small-molecule agonist of KIF2C enhances DNA repair in two distinct genetic disorders exhibiting DNA damage and accelerated aging, the Hutchinson-Gilford progeria (HGPS) and Down (DS) syndromes. Mechanistically, the KIF2C agonist improves the repair of DNA double-strand breaks by inducing nuclear envelope invaginations poked by cytoplasmic microtubules, which translated into amended epigenetic and transcriptional signatures of HGPS and DS. Moreover, subcutaneous administration of the KIF2C agonist in progeria mice mitigated aging phenotypes, extending their healthspan. Our study discloses a unique geroprotective pharmacological approach targeting DNA damage.

Nature Communications
Universidade do Porto (PT), University of Rochester Medical Center (US), Hospital de São João (PT), i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT), Instituto de Biologia Molecular e Celular (PT), Instituto Nacional de Engenharia Biomédica (PT), Instituto de Ciências Biomédicas Albel Salazar (PT), University of Rochester (US)
Université de Montréal, Fundação para a Ciência e a Tecnologia, European Regional Development Fund
Good health and well-being
Openalex Percentile: Top 100%
Nuclear Structure and Function
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon